Pack Health and its partners presented findings at the San Antonio Breast Cancer Symposium® (SABCS®) on December 9, 2020 at 8:00 AM. The study, entitled Patient-Reported Outcomes of Newly Diagnosed Women With Breast Cancer Enrolled in a Digital Health Coaching Program was conducted by The University of Texas MD Anderson Cancer Center in collaboration with Pack Health, and sponsored by an unrestricted grant from Genentech.
With breast cancer (BC) treatment primarily managed in the ambulatory setting, opportunities exist to provide support services to individuals that enhance their ability to manage side effects of treatment and their overall health outcomes. Though overall survival is high, the symptom burden of treatment, including pain, fatigue, distress, hot flashes, disturbed sleep, and neuropathic symptoms, can significantly impact treatment experience and health-related quality of life (HrQoL). A recent systematic review suggests digital health interventions can improve HrQoL for cancer patients. The aim of this randomized control trial was to evaluate the effect of a digital health coaching program on patient-reported outcomes (PROs) and experience of women with breast cancer undergoing chemotherapy treatment in the ambulatory setting.
Study participants were assigned to either standard of care support services or to a 12-week digital health coaching program which included weekly calls from a certified Health Advisor accompanied by up to 5 weekly nudges of evidence-based content delivered via text or email that focused on overall health and wellness, including nutrition, exercise, symptom management, physical and psychosocial well-being.
Data was presented during the 2020 San Antonio Breast Cancer Symposium. View the full poster and the results here.